-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/question-what-is-the-etiology-of-cryptorchidism-what-are-the-environmental-factors-maternal-smoking-maternal-diabetes-mellitus-etc-that-may-contribute-to-the-development-of-this-condition-question-what-is-the-ideal-diagnostic
May 10, 2010 - Cryptorchidism is strongly correlated with low birth weight which, as has long been established, is more
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
May 01, 2017 - Nausea
� Vomiting
� Not enough water in your
body (called “dehydration”)
� Loss of appetite
� Weight
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
June 01, 2016 - Kenalog®) shot
��Mood changes
�� Problems with growth
�� Roundness of the face
�� Increased appetite
��Weight
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
May 14, 2010 - increasing age, female sex, decreasing
estrogen levels in women, low testosterone levels in men, low body weight … The FRAX, which takes into account age, year of birth, height,
weight, secondary osteoporosis, femoral
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - for daily insulin administration
to sustain life, maintain normoglycemia,
and maintain normal body weight … associated with an increased risk of hypoglycemia,
a barrier to tight control,7 and can also lead to weight … review that looked at pregnant women
3
with pre-existing type 1 or type 2 diabetes, mean birth
weight … cFetal outcomes include gestational age, birth weight, frequency of neonatal hypoglycemia, birth trauma … Weight gain associated with intensive therapy in the diabetes control
and complications trial.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
February 01, 2016 - Topiramate (Topamax®,
Trokendi XR®, Qudexy XR®)
��Numbness or
tingling*
��Decreased
appetite
��Weight
-
effectivehealthcare.ahrq.gov/products/asthma-nitric-oxide/research-protocol
September 12, 2016 - utility including asthma phenotype, tobacco, inhaled or oral corticosteroids, bronchodilators, patient weight … protocol was followed (alcohol consumption, fasting state or food intake, prior use of mouthwash)
BMI/weight
-
effectivehealthcare.ahrq.gov/products/pediatric-ehr/research-protocol
August 18, 2014 - anthropometric analysis such as growth charts, immunization tracking and forecasting, and support for weight-based … information to support certain functionalities (e.g., immunization, growth and developmental screening, weight-based
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-ehr_research-protocol.pdf
January 01, 2014 - anthropometric analysis such as growth charts, immunization tracking and forecasting, and support for
weight-based … information to support certain functionalities (e.g., immunization, growth and developmental
screening, weight-based
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
January 01, 2014 - osteoarthritis include over-the-counter analgesics and NSAIDs,
exercise and/or physical therapy, and weight … indicated), and oral (not intravenous) colchicine.
7
Diet and lifestyle modifications (e.g., losing weight … analgesics and nonsteroidal
antiinflammatory drugs (NSAIDs), exercise and/or physical therapy, and weight … for knee OA include over-the-counter analgesics and NSAIDs, exercise and/or
physical therapy, and weight … In Bliss-52 and Bliss-76, patients with SLE were given
either 1 mg/kg of body weight or 10 mg/kg doses
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nitric-oxide_research-protocol.pdf
September 06, 2016 - utility including asthma
phenotype, tobacco, inhaled or oral corticosteroids, bronchodilators, patient weight … protocol was followed (alcohol consumption,
fasting state or food intake, prior use of mouthwash)
• BMI/weight
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-knee-physical-therapy_research-protocol.pdf
April 01, 2010 - outcomes of treatments for knee OA.11 Treatment options include pain relievers, anti-
inflammatory drugs, weight … realignment therapy, insole treatment, knee
bracing, wedged orthoses, walking aids, manual therapy, weight
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 81
Long-Term Care for Older Adults: A Review
of Home and Community-Based Services
Versus Institutional Care
Executive Summary
Introduction
Long-term care (LTC) refers to a broad
range of services designed to provide
assistance over prolonged periods to
compensate …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
October 26, 2012 - Template for Reports Developed
Future Research Needs Paper
Number 17
Future Research Needs
for Prevention and
Treatment of Clostridium
difficile Infection
Future Research Needs Paper
Number 17
Future Research Needs for Prevention and Treatment
of Clostridium difficile Infection
Identification o…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - Increases in/worsening of co-morbid symptoms
• Adverse reactions to drug therapies (e.g. somnolence, weight
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - Increases in/worsening of co-morbid symptoms
• Adverse reactions to drug therapies (e.g. somnolence, weight
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
March 14, 2012 - warning signs such as
new onset of symptoms, obstructive symptoms, rectal bleeding, unintentional weight … characteristics (e.g.,
study design, study period, and followup), study participants (e.g., age, sex, race, weight … Potential effect modifiers will be age and weight.
F.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - 1.5% to -1.4%]),
fasting blood glucose levels (-36 mg/dL [-38.4 mg/dL to -33.8 mg/dL]), and body
weight … Weight was reduced by 2.8-3.7 kg (P < 0.05) at 24 weeks in all
except the 20→20 μg/day group. … Subcutaneously released long-term exenatide use could also result
in effective weight loss, several … Among specialists, the key is whether it is likely to improve glucose
control, weight loss as compared … Studies show effect of Bydureon on A1C and
weight for up to three years.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/presentations-future_research.pdf
April 01, 2012 - For example, the future research needs report
on weight gain in pregnancy offered the following narrative … Hill EPC)
12
Reducing the Risk of Primary Breast Cancer (Oregon EPC)13
Outcomes of Maternal Weight … Future Research Needs for Outcomes of Weight
Gain in Pregnancy.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/research-protocol
May 21, 2013 - Colon cancer symptoms include abdominal discomfort, change in bowel habits, anemia, and weight loss.